Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Mariel Metcalfe
  • October 31, 2016
  • News

Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016.

Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016.

Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain and the UK).

read more »

  • Posted by Ben Hope
  • October 27, 2016
  • Blogs

The Internet of Things

The Internet of Things

Evolution from man to machine

The internet of things, the connectivity between man and device, it’s being implemented everywhere, from coffee machines that can be programmed from your bedroom, to wearable technology tracking your heart rate and BMI. However, the idea of the digitally connected patient and HCP is still in its infancy. It begs the question, what will a world where man is interconnected with their machines look like, and how will this impact the healthcare industry? 

read more »

  • Posted by Julie Denny
  • October 26, 2016
  • Events

Research Partnership attends the Pharma Market Research Conference 2016 in Berlin

Research Partnership attends the Pharma Market Research Conference 2016 in Berlin

On 20 – 21 October 2016, Research Partnership attended and exhibited at the Pharma Market Research Conference in Berlin, Germany.
The conference was very well attended, with around 100 delegates participating over the course of the two days.

read more »

  • Posted by Julia Godfrey
  • October 24, 2016
  • News

Therapy Watch expands its oncology portfolio

Therapy Watch expands its oncology portfolio

This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma (RCC).

read more »

  • Posted by Julie Denny
  • October 24, 2016
  • Articles

Time for a new language for asthma?

Time for a new language for asthma?

Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines. A comprehensive market research study has recently been conducted among patients across Asia, in order to try to understand patient perceptions of asthma control and confirms that 50% of patients are uncontrolled. Because patients lack an understanding of what control means, many patients considerably overestimate the extent to which they are successfully managing their condition.

read more »